Good evening :)
Place Order
Add to Watchlist

Alembic Ltd

ALEMBICLTD Share Price

102.063.29% (+3.25)

ALEMBICLTD Share Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,537 cr, stock is ranked 954
High RiskStock is 3.35x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹2,537 cr, stock is ranked 954
High RiskStock is 3.35x as volatile as Nifty

ALEMBICLTD Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
8.071.162.43%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
49.276.300.54%

ALEMBICLTD Analyst Ratings & Forecast

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

ALEMBICLTD Company Profile

Alembic Limited is engaged in the business of pharmaceuticals, real estate and power assets. The Company's segments include API and Real Estate.

ALEMBICLTD Similar Stocks (Peers)

Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
44.07
1Y Return
7.94%
Buy Reco %
88.24
Cipla Ltd
CIPLA
PE Ratio
28.93
1Y Return
1.34%
Buy Reco %
72.73
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
65.78
1Y Return
25.69%
Buy Reco %
68.00
Mankind Pharma Ltd
MANKIND
PE Ratio
51.84
1Y Return
4.96%
Buy Reco %
80.00
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
17.40
1Y Return
3.66%
Buy Reco %
45.16
Compare with Peers

ALEMBICLTD Forecasts

Price

Revenue

Earnings

ALEMBICLTD Share Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

ALEMBICLTD Company Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

ALEMBICLTD Stock EPS (Earnings Per Share) Forecast

Hmm, looks like data is unavailable here. Please come back after some time

ALEMBICLTD

Income

Balance Sheet

Cash Flow

ALEMBICLTD Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 6.73%, vs industry avg of 9.04%

Decreasing Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.07% to 0.06%

Lower than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 4.74%, vs industry avg of 15.28%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue162.76178.13162.32153.26167.3383.79167.40191.50212.26284.62
Raw Materialssubtract37.6450.9739.8645.2124.5911.778.536.928.62120.12
Power & Fuel Costsubtract13.265.461.112.340.910.420.152.021.18
Employee Costsubtract27.0128.6419.6420.5220.7922.6021.4724.0423.03
Selling & Administrative Expensessubtract7.627.387.137.269.177.569.8210.8114.04
Operating & Other expensessubtract45.6453.8046.4530.4115.1920.1024.3353.7353.76
Depreciation/Amortizationsubtract6.145.093.782.633.233.944.866.727.849.35
Interest & Other Itemssubtract0.120.160.170.220.290.360.390.471.112.33
Taxes & Other Itemssubtract-209.18-118.75-118.81-168.43-235.95-325.80-124.20-103.85-165.93-161.56
EPS7.154.434.976.6211.5013.358.657.4210.4612.24
DPS0.120.160.160.160.600.201.802.202.402.40
Payout ratio0.020.040.030.020.050.010.210.300.230.20
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

ALEMBICLTD Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2015

Annual report

PDF
FY 2016

Annual report

PDF
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF
FY 2023

Annual report

PDF
FY 2024

Annual report

PDF
 

ALEMBICLTD Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Alembic Ltd9.451.162.43%
Sun Pharmaceutical Industries Ltd44.076.290.77%
Cipla Ltd28.934.450.88%
Torrent Pharmaceuticals Ltd65.7815.890.87%

ALEMBICLTD Stock Price Comparison

Compare ALEMBICLTD with any stock or ETF
Compare ALEMBICLTD with any stock or ETF
ALEMBICLTD
Loading...

ALEMBICLTD Shareholdings

ALEMBICLTD Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

ALEMBICLTD Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

ALEMBICLTD Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding70.88%0.00%0.06%1.78%27.27%

Mar 2024

Jun 2024

Sep 2024

Dec 2024

ALEMBICLTD Shareholding History

SepDec '23MarJunSepDec '243.36%0.00%0.00%0.00%0.00%0.00%

ALEMBICLTD Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing ALEMBICLTD stock

Looks like this stock is not in any smallcase yet.

ALEMBICLTD Events

ALEMBICLTD Dividend Trend

Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 2.43%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹24.29 every year

Dividends

Corp. Actions

Announcements

Legal Orders

ALEMBICLTD Upcoming Dividends

No upcoming dividends are available

ALEMBICLTD Past Dividends

Cash Dividend

Ex DateEx DateAug 5, 2024

Final
Final | Div/Share: ₹2.40

Dividend/Share

₹2.40

Ex DateEx Date

Aug 5, 2024

Cash Dividend

Ex DateEx DateAug 3, 2023

Final
Final | Div/Share: ₹2.20

Dividend/Share

₹2.20

Ex DateEx Date

Aug 3, 2023

Cash Dividend

Ex DateEx DateSep 12, 2022

Final
Final | Div/Share: ₹1.80

Dividend/Share

₹1.80

Ex DateEx Date

Sep 12, 2022

Cash Dividend

Ex DateEx DateJul 29, 2021

Final
Final | Div/Share: ₹0.20

Dividend/Share

₹0.20

Ex DateEx Date

Jul 29, 2021

Cash Dividend

Ex DateEx DateJul 29, 2020

Final
Final | Div/Share: ₹0.60

Dividend/Share

₹0.60

Ex DateEx Date

Jul 29, 2020

ALEMBICLTD Stock News & Opinions

Spotlight
Alembic Q3 PAT soars to Rs 26 cr

Profit before tax (PBT) was at Rs 27.39 crore in Q3 FY25, up 151.75% as against Rs 10.88 crore reported in the same period a year ago. Total expense jumped 13.79% year on year to Rs 34.90 crore during the quarter. Employee benefit expense stood at Rs 6.56 crore (up 17.56% YoY), while cost of materials consumed was at Rs 1.81 crore (up 14.56% YoY) during the period under review. The company's revenue from the active pharmaceutical ingredients business was at Rs 6.25 crore (down 3.55% YoY), while the real estate business came in at Rs 51.67 crore (up 57.29% YoY) during the period under review. On a 9-month basis, the net profit surged 68.8% to Rs 120.83 crore on a 49.04% rise in revenue from operations to Rs 161.62 crore in 9M FY25 over 9M FY24. Alembic is dealing in the Active Pharmaceutical Ingredient (API) Business and Real Estate Business. Shares of Alembic fell 1.69% to Rs 110.85 on the BSE.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Alembic consolidated net profit rises 6.50% in the December 2024 quarter

Net profit of Alembic rose 6.50% to Rs 65.39 crore in the quarter ended December 2024 as against Rs 61.40 crore during the previous quarter ended December 2023. Sales rose 47.30% to Rs 57.92 crore in the quarter ended December 2024 as against Rs 39.32 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales57.9239.32 47 OPM %45.5829.68 - PBDT30.0813.53 122 PBT27.3910.87 152 NP65.3961.40 6 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Alembic to hold board meeting

Alembic will hold a meeting of the Board of Directors of the Company on 7 February 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Alembic consolidated net profit rises 33.46% in the September 2024 quarter

Net profit of Alembic rose 33.46% to Rs 121.02 crore in the quarter ended September 2024 as against Rs 90.68 crore during the previous quarter ended September 2023. Sales rose 63.91% to Rs 52.91 crore in the quarter ended September 2024 as against Rs 32.28 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales52.9132.28 64 OPM %37.0131.44 - PBDT84.5157.89 46 PBT81.8356.03 46 NP121.0290.68 33 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Alembic announces board meeting date

Alembic will hold a meeting of the Board of Directors of the Company on 8 November 2024Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Alembic consolidated net profit rises 25.78% in the June 2024 quarter

Net profit of Alembic rose 25.78% to Rs 55.82 crore in the quarter ended June 2024 as against Rs 44.38 crore during the previous quarter ended June 2023. Sales rose 37.84% to Rs 50.78 crore in the quarter ended June 2024 as against Rs 36.84 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales50.7836.84 38 OPM %40.1729.53 - PBDT21.8713.38 63 PBT19.3711.55 68 NP55.8244.38 26 Powered by Capital Market - Live

7 months agoCapital Market - Live

Alembic’s shares dip amidst US market product recall

1 year agoThe Hindu Businessline

Housing & Urban Development Corporation Ltd leads gainers in ‘A’ group

2 years agoBusiness Standard

Alembic Ltd leads gainers in ‘A’ group

2 years agoBusiness Standard

This multibagger stock sets record date for 90% dividend

2 years agoLivemint

Frequently asked questions

  1. What is the share price of Alembic Ltd (ALEMBICLTD) today?

    The share price of ALEMBICLTD as on 27th March 2025 is ₹102.06. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Alembic Ltd (ALEMBICLTD) share?

    The past returns of Alembic Ltd (ALEMBICLTD) share are
    • Past 1 week: -0.79%
    • Past 1 month: -0.59%
    • Past 3 months: -23.39%
    • Past 6 months: -27.08%
    • Past 1 year: 27.02%
    • Past 3 years: 29.52%
    • Past 5 years: 186.28%

  3. What are the peers or stocks similar to Alembic Ltd (ALEMBICLTD)?

    The peers or stocks similar to Alembic Ltd (ALEMBICLTD) include:

  4. What is the dividend yield % of Alembic Ltd (ALEMBICLTD) share?

    The current dividend yield of Alembic Ltd (ALEMBICLTD) is 2.43.

  5. What is the market cap of Alembic Ltd (ALEMBICLTD) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Alembic Ltd (ALEMBICLTD) is ₹2537.26 Cr as of 27th March 2025.

  6. What is the 52 week high and low of Alembic Ltd (ALEMBICLTD) share?

    The 52-week high of Alembic Ltd (ALEMBICLTD) is ₹169 and the 52-week low is ₹80.

  7. What is the PE and PB ratio of Alembic Ltd (ALEMBICLTD) stock?

    The P/E (price-to-earnings) ratio of Alembic Ltd (ALEMBICLTD) is 9.45. The P/B (price-to-book) ratio is 1.16.

  8. Which sector does Alembic Ltd (ALEMBICLTD) belong to?

    Alembic Ltd (ALEMBICLTD) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  9. How to buy Alembic Ltd (ALEMBICLTD) shares?

    You can directly buy Alembic Ltd (ALEMBICLTD) shares on Tickertape. Simply sign up, connect your demat account and place your order.